FDA Seeks New Ways To Involve Patients In Regulatory Process
This article was originally published in The Pink Sheet Daily
Executive Summary
Industry hasn’t been shy about suggesting what changes it would like to see in FDA’s existing patient program, and opening of formal docket suggests agency is eager to rethink its approach.